Laboratory Medicine ›› 2026, Vol. 41 ›› Issue (10): 1022-1029.DOI: 10.3969/j.issn.1673-8640.2026.10.014

Previous Articles     Next Articles

Research progress on exosome-derived biomarkers of schizophrenia

FU Xiaomei, JIN Weifeng, LI Dan, CHEN Shuzi, LI Zhenhua, MA Peijun, LIN Ping()   

  1. Department of Clinical Laboratory, Shanghai Mental Health Center,Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China
  • Received:2025-05-13 Revised:2025-12-30 Online:2026-10-30 Published:2026-10-20

Abstract:

The current clinical diagnosis of schizophrenia(SCZ) relies on symptom assessment. There is an urgent need for stable and reliable biomarkers to achieve early identification and precise treatment of SCZ. Exosomes and biological active molecules,such as nucleic acids,proteins and lipids,play roles in the occurrence and development of SCZ,making them a research hotspot. The exosomes and their related components of SCZ patients show specific changes,which are related to the pathophysiological mechanism of SCZ,making them a potential biomarker for SCZ. This review focuses on the research progress of exosome non-coding RNA,proteins,lipids and so on,as potential diagnostic markers for SCZ,providing new theoretical basis and research directions for the development of new diagnostic tools for SCZ.

Key words: Exosome, Non-coding RNA, Schizophrenia, Biomarker

CLC Number: